Avid Bioservices Inc (CDMO)

[biopharm]

AF must be preparing two articles for Peregrine.... IMHO he will have to post how he can't believe the positive results that Peregrine has released and he will not change his mind until a BP agrees to a partnership and puts up the money. 1 out of 5 drugs make it to FDA approval and now with Cotara heading into phase III and Bavi results around the corner and heading to hopeful quick phase III or early approval it puts Peregrine on the very very short list to go from small bio tech to major BP

This makes our partner/buyout potential partners go from not only the biggest 20 or so BP's... but stretches this into the biggest 50 BP's and very possibly a multiple BP partner/buyout where one large BP is mainly focused in US and the other BP is mainly focused outside the US

All in my opinion.... because gaining hold of the entire pipeline is a rather large set of trials to be put in motion and the quicker the trials are placed into motion... the quicker the return for all parties and cancer patients!